Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Neostart Corporation dba AGA Clinical Trials
986
mi
from 43215
Hialeah, FL
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Neostart Corporation dba AGA Clinical Trials
986
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Altus Research
938
mi
from 43215
Lake Worth, FL
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Altus Research
938
mi
from 43215
Lake Worth, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Advanced Research Institute, Inc
814
mi
from 43215
New Port Richey, FL
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Advanced Research Institute, Inc
814
mi
from 43215
New Port Richey, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Healthcare Clinical Data, Inc.
986
mi
from 43215
North Miami, FL
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Healthcare Clinical Data, Inc.
986
mi
from 43215
North Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Clinical Research of West Florida - Tampa
831
mi
from 43215
Tampa, FL
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Clinical Research of West Florida - Tampa
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Visions Clinical Research
934
mi
from 43215
Wellington, FL
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Visions Clinical Research
934
mi
from 43215
Wellington, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Mt. Vernon Clinical Research - Wake Research
423
mi
from 43215
Atlanta, GA
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Mt. Vernon Clinical Research - Wake Research
423
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Brighton Clinical Research Associates
421
mi
from 43215
Norcross, GA
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Brighton Clinical Research Associates
421
mi
from 43215
Norcross, GA
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
MedPharmics, LLC.
797
mi
from 43215
Metairie, LA
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
MedPharmics, LLC.
797
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
New England Center for Clinical Research
631
mi
from 43215
Fall River, MA
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
New England Center for Clinical Research
631
mi
from 43215
Fall River, MA
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Lawrence OB/GYN
439
mi
from 43215
Lawrenceville, NJ
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Lawrence OB/GYN
439
mi
from 43215
Lawrenceville, NJ
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
ProHEALTH Care Associates, LLC - Suffolk OB-GYN
528
mi
from 43215
Port Jefferson, NY
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
ProHEALTH Care Associates, LLC - Suffolk OB-GYN
528
mi
from 43215
Port Jefferson, NY
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Pmg Research Of Salisbury
328
mi
from 43215
Salisbury, NC
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Pmg Research Of Salisbury
328
mi
from 43215
Salisbury, NC
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
PMG Research of Wilmington
484
mi
from 43215
Wilmington, NC
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
PMG Research of Wilmington
484
mi
from 43215
Wilmington, NC
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Complete Health Care for Women
9
mi
from 43215
Columbus, OH
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Complete Health Care for Women
9
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Study Center
2
mi
from 43215
Columbus, OH
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Study Center
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Jackson Clinic, PA
436
mi
from 43215
Jackson, TN
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Jackson Clinic, PA
436
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
1137
mi
from 43215
San Antonio, TX
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated:  12/31/1969
Tidewater Clinical Research
423
mi
from 43215
Norfolk, VA
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Status: Enrolling
Updated: 12/31/1969
Tidewater Clinical Research
423
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
643
mi
from 43215
Boston, MA
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
University of South Alabama Mitchell Cancer Institute
701
mi
from 43215
Mobile, AL
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
University of South Alabama Mitchell Cancer Institute
701
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Augusta University
452
mi
from 43215
Augusta, GA
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Augusta University
452
mi
from 43215
Augusta, GA
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Billings Clinic
1343
mi
from 43215
Billings, MT
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Billings Clinic
1343
mi
from 43215
Billings, MT
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
609
mi
from 43215
Lebanon, NH
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
GHS Cancer Institute
355
mi
from 43215
Greenville, SC
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
GHS Cancer Institute
355
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
A Two-part, Phase 1, Exploratory and Dose-range Finding Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following a Single Subcutaneous Administration of TV-46046 in Women With Ovulatory Cycle
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10183
416
mi
from 43215
Philadelphia, PA
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
A Two-part, Phase 1, Exploratory and Dose-range Finding Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following a Single Subcutaneous Administration of TV-46046 in Women With Ovulatory Cycle
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10183
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
A Two-part, Phase 1, Exploratory and Dose-range Finding Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following a Single Subcutaneous Administration of TV-46046 in Women With Ovulatory Cycle
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 104
423
mi
from 43215
Norfolk, VA
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
A Two-part, Phase 1, Exploratory and Dose-range Finding Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following a Single Subcutaneous Administration of TV-46046 in Women With Ovulatory Cycle
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 104
423
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
479
mi
from 43215
New York, NY
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Maricopa Integrated Health Systems
1662
mi
from 43215
Phoenix, AZ
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Maricopa Integrated Health Systems
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine Medical Center
1958
mi
from 43215
Orange, CA
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine Medical Center
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
UC San Diego Health
1950
mi
from 43215
San Diego, CA
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
UC San Diego Health
1950
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Denver Health Medical Center
1162
mi
from 43215
Denver, CO
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Denver Health Medical Center
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Northwestern Memorial Hospital
274
mi
from 43215
Chicago, IL
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Northwestern Memorial Hospital
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Indiana University Medical Center
166
mi
from 43215
Indianapolis, IN
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Indiana University Medical Center
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Ochsner Baptist Medical Center
800
mi
from 43215
New Orleans, LA
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Ochsner Baptist Medical Center
800
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Boston Med Ctr
642
mi
from 43215
Boston, MA
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Boston Med Ctr
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Baystate Medical Center
563
mi
from 43215
Springfield, MA
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Baystate Medical Center
563
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Hospital
416
mi
from 43215
Philadelphia, PA
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospital
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Regional Obstetrical Consultants
361
mi
from 43215
Chattanooga, TN
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Regional Obstetrical Consultants
361
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
University of Texas Medical Branch
992
mi
from 43215
Galveston, TX
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
University of Texas Medical Branch
992
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Sciences University
2026
mi
from 43215
Portland, OR
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Sciences University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
1154
mi
from 43215
Aurora, CO
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated:  12/31/1969
Greenville Health System
357
mi
from 43215
Greenville, SC
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Status: Enrolling
Updated: 12/31/1969
Greenville Health System
357
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
A Novel Method of Restoring Menstrual Cyclicity or Ovulatory Function in PCOS Patients: The Use of CPAP to Improve More Than Sleep Quality
Status: Enrolling
Updated:  12/31/1969
University of Louisville Fertility Center
184
mi
from 43215
Louisville, KY
Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
A Novel Method of Restoring Menstrual Cyclicity or Ovulatory Function in PCOS Patients: The Use of CPAP to Improve More Than Sleep Quality
Status: Enrolling
Updated: 12/31/1969
University of Louisville Fertility Center
184
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Pregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Pregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospital
318
mi
from 43215
Falls Church, VA
Pregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Pregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospital
318
mi
from 43215
Falls Church, VA
Click here to add this to my saved trials